> Israel's Oramed ($ORMD) said enrollment in the Phase IIb study of its drug delivering capsule for Type 2 diabetes is more than halfway complete. More
> The National Science Foundation awarded New York University's Polytechnic School of Engineering a three-year $300,000 grant to study drug delivery related to siRNA. More